AMFM Healthcare invites you to a
Continuing Education Event
Register Now

Long-Acting Injectable (LAI) Antipsychotics

In Bipolar Disorder and Schizophrenia: A Therapeutic Approach
Wednesday, June 12, 2024
1:00 pm – 2:00 pm EDT
1.5 CEU Credit
Cost: FREE
Mental health professionals play a pivotal role in the treatment journey of individuals diagnosed with schizophrenia or bipolar disorder. This continuing education activity offers an enriching exploration of long-acting injectable (LAI) antipsychotics from a therapeutic standpoint, providing psychiatric and mental health professionals with essential insights to enhance patient care. Participants will navigate through a comprehensive review, gaining a nuanced understanding of how LAI antipsychotics can effectively augment treatment strategies for both bipolar disorder and schizophrenia. Through a blend of theoretical discourse and practical application, attendees will examine the therapeutic potential, benefits, and challenges associated with integrating LAI antipsychotics into clinical practice. This activity offers a platform for in-depth discussion surrounding the unique considerations involved in utilizing LAI antipsychotics across varying patient populations. Attendees will emerge equipped with evidence-based knowledge to make informed decisions, provide valuable patient and family education and support clients in their journey to optimal wellness.

LEARNING OBJECTIVES

  • Define the diagnostic criteria and clinical manifestations of bipolar disorder and schizophrenia.
  • Evaluate the role of long-acting injectable (LAI) antipsychotics in the treatment of bipolar disorder and schizophrenia.
  • Identify the benefits and challenges associated with the use of LAI antipsychotics in clinical practice.
  • Compare and contrast different types of LAI antipsychotics available for the management of bipolar disorder
    and schizophrenia.
  • Compare and contrast different types of LAI antipsychotics available for the management of bipolar disorder
    and schizophrenia.
  • Discuss the therapeutic perspective of utilizing LAI antipsychotics as part of a comprehensive treatment approach for
    bipolar disorder and schizophrenia.
  • Develop strategies to address patient concerns and improve adherence to LAI antipsychotic treatment regimens.
Register Now

Share:

Presented By

Thumbnail

Kirby P. Williams, MSN, PMHNP-BC

Kirby P. Williams has worked as a mental health nurse practitioner since 2012 and enjoys mentoring and supporting future psychiatric nurse practitioners. From 2013-2022, she has worked in nursing academia in undergraduate and graduate level courses covering various mental health topics. As the owner of her private practice Beacon Behavioral Health and Consulting in Virginia, she provides psychiatric services. Her mental health specialties include: major depressive disorder, bipolar spectrum disorders, psychotic disorders, older adult conditions, PTSD and anxiety disorders.